KPC Pharmaceuticals

KPC Pharmaceuticals EBIT Margin

The EBIT Margin (Operating Margin) of KPC Pharmaceuticals (600422.SS) as of Nov 4, 2026 is 7.20 %. In the previous year, EBIT Margin (Operating Margin) was 11.19 % — a change of -35.67% (lower).

EBIT Margin

7.20 %

YoY

-35.67%

Last updated:

EBIT Margin (Operating Margin) of KPC Pharmaceuticals is 2025 7.20 % . EBIT Margin (Operating Margin) of KPC Pharmaceuticals was 2024 11.19 % . It decreases by -35.67% lower compared to the previous year.

KPC Pharmaceuticals's operating (EBIT) margin stands at 7.2%, broadly stable from 7.7% several years earlier.

The KPC Pharmaceuticals EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
5.91 CNY
Jan 1, 2019
7.12 CNY
Jan 1, 2020
7.01 CNY
Jan 1, 2021
7.68 CNY
Jan 1, 2022
6.00 CNY
Jan 1, 2023
9.37 CNY
Jan 1, 2024
11.19 CNY
Jan 1, 2025
7.20 CNY
The KPC Pharmaceuticals EBIT Margin history
YEAREBIT MarginYoY
7.20 %-35.67%
11.19 %+19.49%
9.37 %+56.05%
6.00 %-21.86%
7.68 %+9.62%
7.01 %-1.50%
7.12 %+20.37%
5.91 %-16.02%
7.04 %-19.18%
8.71 %-8.01%
9.47 %+22.80%
7.71 %+10,287.25%
0.07 %-5.33%
0.08 %+9.42%
0.07 %+17.08%
0.06 %+3.39%
0.06 %+101.30%
0.03 %-47.19%
0.06 %+220.37%
0.02 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KPC Pharmaceuticals Stock analysis

What does KPC Pharmaceuticals do? KPC Pharmaceuticals, Inc. generates revenue through the research, development, manufacturing, and international marketing of its diverse drug portfolio. The company sells natural herbal medicines, traditional Chinese medicines, and chemical synthetic drugs, including central nervous system drugs, cardiovascular and cerebrovascular drugs, anti-parasitic drugs, anti-microbial drugs, anti-gout drugs, hormones and endocrine drugs, hemorrhoids medicines, and anti-inflammatory drugs. Its main customers are healthcare providers, hospitals, and pharmaceutical distributors globally. The firm also produces health products and offers medical services as additional revenue streams. The company's product segments are defined by therapeutic categories such as central nervous system treatments, cardiovascular care, and anti-inflammatory solutions. These products target both domestic and international markets, with a focus on traditional Chinese medicine and natural herbal formulations. Sales are driven by wholesale distribution networks and direct commercial partnerships in the pharmaceutical industry. KPC Pharmaceuticals' revenue model combines product sales from its core drug lines with supplementary health product offerings and medical service provision. The business leverages its manufacturing capabilities in Kunming, Yunnan to serve global markets, with a strong emphasis on traditional Chinese medicine and natural herbal medicine segments. The firm's international marketing efforts support its presence in multiple regions. KPC Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KPC Pharmaceuticals stock

EBIT Margin (Operating Margin) of KPC Pharmaceuticals is 7.20 % in 2025.

EBIT Margin (Operating Margin) of KPC Pharmaceuticals changed from 11.19 % to 7.20 %, representing a -35.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) KPC Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s KPC Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — KPC Pharmaceuticals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — KPC Pharmaceuticals